Zobrazeno 1 - 10
of 238
pro vyhledávání: '"inotropic drugs"'
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 19, Iss 4, Pp 31-43 (2022)
The objective: to study hemodynamic and clinical effects of levosimendan depending on the clinical outcome in patients with sepsis and impaired cardiac pumping function.Subjects and Methods. the retrospective study involved 31 patients of 52.7 ± 2.8
Externí odkaz:
https://doaj.org/article/97653d6184a3479dacbcb26a78a49e0b
Autor:
Edimar Alcides Bocchi, Ivna Girard Cunha Vieira Lima, Bruno Biselli, Vera Maria Cury Salemi, Silvia Moreira Ayub Ferreira, Paulo Roberto Chizzola, Robinson Tadeu Munhoz, Ranna Santos Pessoa, Francisco Akira Malta Cardoso, Mariana Vieira de Oliveira Bello, Ludhmila Abrahão Hajjar, Brenno Rizerio Gomes
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 943-952 (2021)
Abstract Aims Patients with advanced heart failure (HF) with reduced left ventricular ejection fraction (HFrEF) and concurrent coronavirus disease 2019 (COVID‐19) might have a higher risk of severe events. Methods and results We retrospectively stu
Externí odkaz:
https://doaj.org/article/6003443ed7a34f9ba23a956a54e13795
Pharmacological therapy of acute heart failure: what is available now and what is expected in future
Autor:
A. A. Eremenko
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 17, Iss 2, Pp 29-37 (2020)
The objective: to present an overview of current approaches to pharmacological therapy of acute heart failure (AHF).Results: the discussion focuses on drugs that are currently available and being actively studied in ongoing clinical trials. Disadvant
Externí odkaz:
https://doaj.org/article/93b5c1bbb921413c9caf56bb4b4557c3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Yu. Giljarov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 4, Iss 5, Pp 67-70 (2016)
Dobutamine is inotropic drug indicated in systolic dysfunction. Data on dobutamine pharmacology, its effects on hemodynamics, coronary and peripheral blood flow, myocardial electrophysiology are presented. Clinical usage and the main contraindication
Externí odkaz:
https://doaj.org/article/25c6e7ad058c430a932f76dd9227e785
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Insha Ali, Masood Ahmad Sheikh
Publikováno v:
International Journal of Advanced Research. 9:604-609
Nowadays we are observing there are enough number of cardiovascular patients and also day by day their ratio is getting increased at huge number becauseCardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 milli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ac80f6831f73538078c6e6e155cd30
https://doi.org/10.21474/ijar01/12488
https://doi.org/10.21474/ijar01/12488
Publikováno v:
Archives of Medical Science : AMS
Acute decompensated heart failure (ADHF) is a common clinical problem associated with a high mortality rate. Because ADHF has various aetiologies, there are a range of therapeutic options, among others, positive inotropes (inotropic drugs). As an ino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0133e7c90607b8ba53ae57efad243e3c
https://doi.org/10.5114/aoms.2018.77055
https://doi.org/10.5114/aoms.2018.77055
Autor:
Francisco Akira Malta Cardoso, Ranna Santos Pessoa, Silvia Moreira Ayub Ferreira, Bruno Biselli, Mariana Vieira de Oliveira Bello, Vera Maria Cury Salemi, Ludhmila Abrahão Hajjar, Ivna Girard Cunha Vieira Lima, Brenno Rizerio Gomes, Edimar Alcides Bocchi, Paulo Roberto Chizzola, Robinson Tadeu Munhoz
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 2, Pp 943-952 (2021)
ESC Heart Failure, Vol 8, Iss 2, Pp 943-952 (2021)
Aims Patients with advanced heart failure (HF) with reduced left ventricular ejection fraction (HFrEF) and concurrent coronavirus disease 2019 (COVID‐19) might have a higher risk of severe events. Methods and results We retrospectively studied 16 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d2f5f2426974a4f12c650206747fd0
https://doi.org/10.1002/ehf2.13199
https://doi.org/10.1002/ehf2.13199
Publikováno v:
Терапевтический архив, Vol 84, Iss 9, Pp 83-88 (2012)
Aim. To evaluate the efficiency and safety of intravenous infusion of levosimendan in patients with idiopathic pulmonary hypertension (IPH) and its clinical, hemodynamic, and neurohumoral effects. Subjects and methods. The study included 9 patients (
Externí odkaz:
https://doaj.org/article/f322fa2efc6e4f20908e69ba21ab443e